Basilea Pharmaceutica AG (LON:0QNA)

Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	610	630	442	394	490	393
Market Cap Growth	21.01%	42.55%	12.05%	-19.52%	24.78%	-17.40%
Enterprise Value	543	600	485	471	571	447
Last Close Price	49.83	51.25	36.45	33.42	41.15	33.38
PE Ratio	16.17	16.70	6.46	40.47	44.94	-
PS Ratio	2.80	2.89	2.40	2.68	3.69	3.27
PB Ratio	5.09	5.25	6.19	-42.28	-26.35	-8.27
P/TBV Ratio	5.10	5.27	6.22	-	-	-
P/FCF Ratio	10.94	11.30	6.90	31.48	139.32	-
P/OCF Ratio	10.48	10.83	6.74	29.69	77.36	-
EV/Sales Ratio	2.45	2.76	2.64	3.20	4.31	3.72
EV/EBITDA Ratio	10.13	11.85	8.68	21.78	29.31	154.82
EV/EBIT Ratio	10.91	12.26	8.93	23.05	30.58	183.33
EV/FCF Ratio	9.74	10.77	7.58	37.59	162.43	-
Debt / Equity Ratio	0.70	0.70	1.38	-12.86	-9.03	-3.74
Debt / EBITDA Ratio	1.59	1.59	1.71	5.05	7.76	41.61
Debt / FCF Ratio	1.50	1.50	1.54	9.57	47.76	-
Net Debt / Equity Ratio	-0.55	-0.55	-0.11	-6.86	-4.95	-1.20
Net Debt / EBITDA Ratio	-1.30	-1.30	-0.14	2.96	4.72	19.72
Net Debt / FCF Ratio	-1.19	-1.19	-0.12	5.11	26.16	-2.15
Asset Turnover	0.86	0.86	0.97	0.80	0.63	0.62
Inventory Turnover	5.46	5.46	3.99	4.13	4.18	5.33
Quick Ratio	4.53	4.53	3.93	2.48	1.96	1.22
Current Ratio	5.12	5.12	4.85	3.20	2.34	1.38
Return on Equity (ROE)	38.52%	38.52%	218.58%	-	-	-
Return on Assets (ROA)	12.10%	12.10%	17.89%	6.95%	5.56%	0.79%
Return on Invested Capital (ROIC)	79.90%	70.88%	94.46%	31.17%	44.56%	-
Return on Capital Employed (ROCE)	22.40%	22.40%	29.10%	17.40%	14.30%	4.10%
Earnings Yield	6.18%	5.99%	15.48%	2.47%	2.23%	-1.41%
FCF Yield	9.14%	8.85%	14.50%	3.18%	0.72%	-6.73%
Buyback Yield / Dilution	1.23%	1.23%	-14.10%	-1.67%	-2.24%	-13.62%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.